Metastasiertes Prostatakarzinom

Metastasiertes hormonsensitives Prostatakarzinom
mHSPC

Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (AMPLITUDE)

Ausführliche Informationen


Metastasiertes kastrationsresistentes Prostatakarzinom
mCRPC

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (MK-3475-641/KEYNOTE-641)

Ausführliche Informationen


Metastasiertes kastrationsresistentes Prostatakarzinom
mCRPC

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Ausführliche Informationen